Literature DB >> 33360570

Characterization of four types of MLV-derived porcine reproductive and respiratory syndrome viruses isolated in unvaccinated pigs from 2016 to 2020.

Nanhua Chen1, Xinshuai Li2, Yanzhao Xiao2, Shubin Li2, Jianzhong Zhu3.   

Abstract

Modified live vaccines (MLVs) have been utilized to combat porcine reproductive and respiratory syndrome (PRRS), which raises a serious concern about the MLV-derived PRRS virus (PRRSV) isolates. During the routine investigation of PRRSV in China, four lung samples collected from unvaccinated diseased pigs from 2016 to 2020 were detected as PRRSV positive. The PRRSVs shared high ORF5 identities to CH-1R, JXA1-R, TJM-F92 and RespPRRS MLV vaccines, respectively. The viruses were isolated in Marc-145 cells and denominated as SD1612-1, JS1703-21, JSTZ1907-714 and JSYC20-05-1. Genome comparison confirmed that these isolates share the highest genomic homologies to CH-1R (97.96%), JXA1-R (99.64%), TJM-F92 (99.00%) and RespPRRS MLV (99.57%) than any other known isolates. Genome-based phylogenetic analysis showed that SD1612-1 and CH-1R, JS1703-21 and JXA1-R, JSTZ1907-714 and TJM-F92, JSYC20-05-1 and RespPRRS MLV were grouped in the same branches. In addition, amino acids unique to corresponding vaccine attenuations were also identified in our isolates. Noticeably, amino-acids potentially associated with the virulence revision from MLV strains to parental virulent viruses were also identified in the MLV-derived isolates. Our results confirm that the four types of MLV-derived isolates are circulating and evolving in Chinese swine herds for years, which highlights the necessity for the fair use of PRRS MLVs.
Copyright © 2020. Published by Elsevier Ltd.

Entities:  

Keywords:  Complete genome; MLV-derived isolates; PRRSV; Virulence reversion

Year:  2020        PMID: 33360570     DOI: 10.1016/j.rvsc.2020.12.007

Source DB:  PubMed          Journal:  Res Vet Sci        ISSN: 0034-5288            Impact factor:   2.534


  7 in total

1.  Evolution Characterization and Pathogenicity of a Porcine Reproductive and Respiratory Syndrome Virus Isolate from a Pig Farm in Shandong Province, China.

Authors:  Yulin Xu; Xiaojing Ji; Chunyu Fu; Dong Hu; Heng Pang; Tingting Wang; Chuangang Li; Gang Wang; Jun Peng
Journal:  Viruses       Date:  2022-05-31       Impact factor: 5.818

Review 2.  Research Progress in Porcine Reproductive and Respiratory Syndrome Virus-Host Protein Interactions.

Authors:  Hang Zhang; Huiyang Sha; Limei Qin; Nina Wang; Weili Kong; Liangzong Huang; Mengmeng Zhao
Journal:  Animals (Basel)       Date:  2022-05-27       Impact factor: 3.231

Review 3.  The Function of the PRRSV-Host Interactions and Their Effects on Viral Replication and Propagation in Antiviral Strategies.

Authors:  Jun Ma; Lulu Ma; Meiting Yang; Wei Wu; Wenhai Feng; Zhongzhou Chen
Journal:  Vaccines (Basel)       Date:  2021-04-09

4.  A Systematic Investigation Unveils High Coinfection Status of Porcine Parvovirus Types 1 through 7 in China from 2016 to 2020.

Authors:  Jixiang Li; Yanzhao Xiao; Ming Qiu; Xinshuai Li; Shubin Li; Hong Lin; Xiangdong Li; Jianzhong Zhu; Nanhua Chen
Journal:  Microbiol Spectr       Date:  2021-12-01

5.  Epidemiological and Genetic Characteristics of Porcine Reproductive and Respiratory Syndrome Virus in South China Between 2017 and 2021.

Authors:  Kui Fang; Shudan Liu; Xiangmin Li; Huanchun Chen; Ping Qian
Journal:  Front Vet Sci       Date:  2022-04-08

6.  CD163-Expressing Porcine Macrophages Support NADC30-like and NADC34-like PRRSV Infections.

Authors:  Yulin Xu; Mengxue Ye; Shaohua Sun; Qi Cao; Jia Luo; Yuening Wang; Wanglong Zheng; François Meurens; Nanhua Chen; Jianzhong Zhu
Journal:  Viruses       Date:  2022-09-16       Impact factor: 5.818

7.  Chimeric HP-PRRSV2 containing an ORF2-6 consensus sequence induces antibodies with broadly neutralizing activity and confers cross protection against virulent NADC30-like isolate.

Authors:  Nanhua Chen; Shubin Li; Yunfei Tian; Xinshuai Li; Shuai Li; Jixiang Li; Ming Qiu; Zhe Sun; Yanzhao Xiao; Xilin Yan; Hong Lin; Xiuling Yu; Kegong Tian; Shaobin Shang; Jianzhong Zhu
Journal:  Vet Res       Date:  2021-05-27       Impact factor: 3.683

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.